Rana Al-Hallaq - Profile and Investment Details

Investor Profile

Rana Al-Hallaq is a Venture Capital, Angel/Individual, Investor based in New York City, New York, United States with a diverse investment portfolio that includes companies such as Jnana Therapeutics, Montis Biosciences, Autifony Therapeutics, Blade Therapeutics, RefleXion Medical, Arkuda Therapeutics, Mitokinin Inc, Vivet Therapeutics, Triplet Therapeutics, ReCode Therapeutics, Pfizer, NY BIO. Over time, Rana Al-Hallaq has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Rana Al-Hallaq is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Immunotherapy, Engineering, Education, Bioinformatics, Biotechnology, Medical, Information Technology, B2B, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Rana Al-Hallaq, as their portfolio suggests a familiarity and interest in this area.

Understanding Rana Al-Hallaq’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.